Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Find out Which Altcoins Have Active Contributors to gauge community health and collaboration across developers and teams.
26,356 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Ether is testing a critical resistance after defending the $1.5K zone again. A daily close above $1.8K could signal a...
Robinhood launched a new layer-2 blockchain to tokenized real-world assets, yet the initial trading frenzy centered o...
Analyzing triple flag (tfpm) 2025 Q4 results helps you gauge resilience in a volatile gold market. This guide breaks ...
Viemed's 2025 earnings outlook hinges on growing demand for home respiratory care, reimbursement dynamics, and cost c...
Investors pulled back from spot XRP ETFs this week, registering zero net inflows across seven trading sessions. XRP p...
Two funds track the same Nasdaq-100 index, but a lower expense ratio gives Invesco NASDAQ 100 ETF a quiet advantage f...
Ares Capital's dividend looks tempting to many income investors, but sustainability hinges on cash flow, loan quality...
PulsePlay tops Deloitte’s North American fastest-growing software list, catalyzing investor interest as users earn mo...
Investors are watching Apple’s latest Siri reveal to see if it marks a meaningful AI leap or just another upgrade. Th...
Seltz announced a $12.5 million seed round to redefine how AI agents surface information. The funding underscores a g...
Artificial intelligence is remaking markets. This guide explains why leaders Nvidia, Palantir, and Meta matter for in...